Table 1.
Main characteristics of the population study
| Characteristics, n = 111 |
stable weight (n = 77) |
changing weight (n = 34) |
P | |
| Median age (years (range)) | 54 (32 - 74) | 53 (37 - 70) | 54 (32 - 74) | 0,49 |
| n (%) | ||||
| Median BMI | 24.4 (17.1 - 40.5) | 24.6 (17.1 - 40.5) | 24.4 (16.6 - 40.5) | 0,14 |
| underweight | 9 (8) | 7 (9) | 2 (6) | |
| normal | 56 (50) | 36 (47) | 20 (59) | |
| overweight | 31 (28) | 21 (27) | 10 (29) | |
| obese | 15 (14) | 13 (17) | 2 (6) | |
| Menopausal status | 0,78 | |||
| Premenopausal | 50 (45) | 34 (44) | 16 (47) | |
| Menopausal | 61 (55) | 43 (56) | 18 (53) | |
| Oestrogene receptors | 0,61 | |||
| Positive | 47 (42) | 32 (42) | 15 (44) | |
| Negative | 48 (44) | 35 (45) | 13 (38) | |
| Progesteron receptors | 0,73 | |||
| Positive | 39 (35) | 29 (38) | 10 (29) | |
| Negative | 52 (47) | 37 (48) | 15 (44) | |
| Tumor stage | 0,99 | |||
| T1 | 21 (19) | 15 (19) | 6 (18) | |
| T2 | 49 (44) | 34 (44) | 15 (44) | |
| T3 | 17 (15) | 12 (16) | 5 (18) | |
| T4 | 24 (22) | 16 (21) | 8 (24) | |
| Clinical node involvement | 0,34 | |||
| N0 | 55 (50) | 34 (44) | 21 (62) | |
| N1 | 49 (44) | 37 (48) | 12 (35) | |
| N2 | 6 (5) | 5 (6) | 1 (3) | |
| N3 | 1 (1) | 1 (1) | ||
| SBR grade | 0,17 | |||
| I | 9 (8) | 8 (10) | 1 (3) | |
| II | 61 (55) | 40 (52) | 21 (62) | |
| III | 22 (20) | 8 (10) | 4 (12) | |